Photocure
Vær den første som følger denne virksomhed
Photocure is a medical technology company. The company specializes in solutions for photodynamic technology. The solutions are used to treat diseases that have caused bladder cancer and HPV. The main markets are in dermatology and oncology, where the products are used by hospitals and research institutes on a global level. The company was founded in 1993 and is headquartered in Oslo, Norway.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
PHO
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Delårsrapport
15.05.2024
Generalforsamling
23.05.2024
Delårsrapport
07.08.2024
Delårsrapport
13.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Morgan Stanley & Co. LLC | 15,5 % | 15,5 % |
SEB | 7,2 % | 7,2 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Photocure: New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
PHO: Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools